secwatch.observer — SEC 8-K summary
======================================

Issuer:     ORAGENICS INC (OGEN)
CIK:        0001174940
Form:       8-K
Filed at:   2022-12-20T23:59:59+00:00
Accession:  0001493152-22-036020
Event type: regulatory
Sentiment:  negative
Materiality: 0.80
Item codes: 3.01, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Oragenics receives NYSE American deficiency notice for low stock price; must cure by June 19, 2023
--------------------------------------------------------------------------------

- NYSE American notified OGEN that its 30-day average stock price fell below $0.20, violating Section 1003(f)(v).
- Stock will trade with 'BC' designation indicating non-compliance; delisting not immediate.
- Company has until June 19, 2023 to demonstrate sustained price improvement or effect a reverse stock split.
- If not cured by deadline, NYSE American may commence delisting proceedings, threatening liquidity and listing status.
- Company intends to monitor price and consider options; no impact on business operations or SEC reporting requirements.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1174940/000149315222036020/0001493152-22-036020-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1174940/000149315222036020/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-22-036020

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer